diablosho
Active member
I realize this study is for oral formestane and post-menopausal breast cancer patients (obviously women
), but here is a study that shows 15% drop in SHBG at 250mg orally:
Invalid Link Removed
So I guess if one was to simply drop formestane without tapering, wouldn't there be more available estrogen to act on breast/hypothalamus? Just speculating, but I've spent a lot of time thinking about the causes of "rebound gyno" after a SD cycle, and I speculate that SHBG plays a very large role in this phenomenon.
Invalid Link Removed
So I guess if one was to simply drop formestane without tapering, wouldn't there be more available estrogen to act on breast/hypothalamus? Just speculating, but I've spent a lot of time thinking about the causes of "rebound gyno" after a SD cycle, and I speculate that SHBG plays a very large role in this phenomenon.